Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.252ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.252ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.252NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.223ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.223ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.223ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.223NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.640.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.640.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.640.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.640.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.11 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.11 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.11 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.11 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.428ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.428ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.428ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.428NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.355ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.355ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.355ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.355NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17890.7US
AY.34.1.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.34.1.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.34.1.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.34.1.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.71 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.71 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.71 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.71 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.33.2 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.33.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.33.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.33.2 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.52ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.52ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.52NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.465ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.465ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.465ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.465NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used